REVEALED: Joe Biden’s incoming chief of staff said elections are rigged

As the big tech tyrants tighten their grip, join us for more free speech at Parler—the anti-censorship social media platform.

The long-serving aide to former Vice President Joe Biden and now-named White House chief of staff has expressed that he believes the elections are rigged and has denied the COVID-19 epidemic in America.

In 2014, Ronald Klain responded to a Vox.com article that reported that "68% of Americans think elections are rigged" at the time. Klain commented: “That’s because they are.”

Focused on gerrymandering, the piece argued, according to a Rasmussen poll, that voters were "basically right" to suspect that elections were “rigged in favor of incumbents."

"The term 'rigged' might go a tad far. The problem here isn’t fraud. In elections, like in so much else, the scandal is what’s legal," Vox founder Ezra Klein levelled.

The same reasoning could be applied to mass mail-in voting, which was introduced in the middle of the 2020 presidential campaign. An early November poll by Politico found that 70 percent of Republicans do not think the general election was "free and fair."

"We don't have a #COVID-19 epidemic in the US but we are starting to see a fear epidemic," Klain tweeted in February of this year. Then he extended "kudos" to New York City Mayor Bill de Blasio among others "for standing against that."

Former President Barack Obama appointed Klain to the so-called Ebola czar position to manage the administration’s handling of the emerging public health crisis after a series of missteps by the Centers for Disease Control and Prevention. Now Klain is seen as an asset in dealing with the coronavirus pandemic.

On Wednesday evening, Biden himself commended Klain's "deep, varied experience and capacity to work with people all across the political spectrum," which he emphasized is "precisely" what he needs in a White House chief of staff to "confront this moment of crisis and bring our country together again."

Massachusetts Sen. Elizabeth Warren called Klain a “superb choice” to serve as Biden’s top adviser. "He understands the magnitude of the health and economic crisis and he has the experience to lead this next administration through it. Ron has earned trust all across the entire Democratic Party."

Warren stated that she's known Klain, asserting that he's "guided by his belief in public service and building opportunity for America’s working families."

In the 2000s, Biden's pick lobbied at the firm O’Melveny & Myers on behalf of a trade coalition that sought to limit payouts in asbestos-related lawsuits. Klain and two others lobbied for the Coalition for Asbestos Resolution to push H.R. 1283 that would cap attorneys fees in such lawsuits and curb liability payouts, Senate lobbying records cite.

As Politico noted in a 2008 expose, watchdog Public Citizen called the bill “a classic example of how special interests in Washington use political contributions, high-powered lobbying and public relations firms and prestigious academics to work their will in Congress — and trample on the rights of workers and consumers in the process.”

Klain was additionally hired by drugmaker ImClone which was heavily criticized for withholding promising experimental medicine from desperate cancer patients. Klain lobbied on “compassionate use” laws that allowed drug distribution before FDA approval. Out of 10,000 patient applications for C-225, ImClone handed out only 30 doses. Shortly after a congressional hearing—where the ImClone’s CEO admitted to the poor drug allocation—the contract was ended with Klain's firm.

He also lobbied on regulatory issues for home lender Fannie Mae, which was accused of inflating its earnings and overpaying executives. The mortgage loan company paid $400 million in fines due to its accounting practices and excessive bonuses to upper management.

Klain’s history as a lobbyist nearly two decades ago is effectively omitted from his progressive resume, perhaps due to his work for major corporations supported by Big Business.